KERLONE Side Effects

6642601-6 | Oedema Peripheral, Segmented Hyalinising Vasculitis, Urticaria
on Mar 15, 2010 Female patient from FRANCE , 47 years of age, was treated with Kerlone (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, segmented hyalinising vasculitis, urticaria. Kerlone dosage: . During the same period patient was treated with LODOZ (View Lodoz Review and Lodoz Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6375809-8 | Hepatocellular Injury, Jaundice
Patient was taking Kerlone (View Usage). Patient had the following side effects: hepatocellular injury, jaundice (What is jaundice?) on Sep 16, 2009 from FRANCE Additional patient health information: Male patient , 49 years of age, was diagnosed with hypertension and. Kerlone dosage: Unk. Patient was hospitalized.

5476077-1 | Hallucinations, Mixed
Adverse event was reported on Sep 27, 2007 by a Female patient taking Kerlone (View Usage) (Dosage: ) was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and. Location: FRANCE , weighting 132.3 lb, After Kerlone was administered, patient had the following side effects: hallucinations, mixed. During the same period patient was treated with PREVISCAN (3/4 Tablet At Bedtime) (View Previscan Review and Previscan Label ), IRBESARTAN (75 Mg) (View Irbesartan Review and Irbesartan Label ).

5421118-0 | Hallucinations, Mixed
on Jul 02, 2007 Female patient from FRANCE , 60 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Kerlone (View Usage). Patient experienced the following unwanted or unexpected effects: hallucinations, mixed. Kerlone dosage: .


5217496-8 | Retinal Artery Occlusion, Visual Acuity Reduced
on Jan 15, 2007 Female patient from FRANCE , 64 years of age, weighting 125.7 lb, was diagnosed with depression (What is depression?) and was treated with Kerlone (View Usage). Patient had the following side effects: retinal artery occlusion, visual acuity reduced. Kerlone dosage: 10 Mg. During the same period patient was treated with RIVOTRIL (Unk) (View Rivotril Review and Rivotril Label ), PIASCLEDINE (View Piascledine Review and Piascledine Label ), ARTHROTEC (2 Unit) (View Arthrotec Review and Arthrotec Label ), PROZAC (View Prozac Review and Prozac Label ).

5201455-5 | Bradycardia Foetal, Caesarean Section, Foetal Distress Syndrome, Foetal Growth Retardation, Hypoglycaemia Neonatal, Meconium Stain, Tricuspid Valve Incompetence
Patient was taking Kerlone (View Usage). After Kerlone was administered, patient had the following side effects: bradycardia foetal, caesarean section, foetal distress syndrome, foetal growth retardation, hypoglycaemia neonatal, meconium stain, tricuspid valve incompetence on Dec 27, 2006 from FRANCE Additional patient health information: Male patient , weighting 5.73 lb, . Kerlone dosage: . Patient was hospitalized.

4713377-4 | Atrial Flutter, Oedema Peripheral, Pericardial Effusion
Adverse event was reported on Jul 06, 2005 by a Female patient taking Kerlone (View Usage) (Dosage: ) . Location: FRANCE , 68 years of age, Patient experienced the following unwanted or unexpected effects: atrial flutter, oedema peripheral, pericardial effusion. During the same period patient was treated with MODOPAR (125 Mg Five Times A Day 625 Mg) (View Modopar Review and Modopar Label ), MODOPAR LP (View Modopar Lp Review and Modopar Lp Label ), MODOPAR DISPERSIBLE (View Modopar Dispersible Review and Modopar Dispersible Label ), CELANCE (View Celance Review and Celance Label ), FORLAX (20 G) (View Forlax Review and Forlax Label ), HEPTAMYL (4 Unit) (View Heptamyl Review and Heptamyl Label ), EFFEXOR (75 Mg) (View Effexor Review and Effexor Label ), XANAX (0.75 Mg) (View Xanax Review and Xanax Label ). Patient was hospitalized.

4707361-4 | Hypoxia, Pneumonitis
on Jun 03, 2005 Female patient from FRANCE , 74 years of age, weighting 176.4 lb, was diagnosed with hypertension, essential hypertension and was treated with Kerlone (View Usage). Patient had the following side effects: hypoxia, pneumonitis. Kerlone dosage: Unk. During the same period patient was treated with COTAREG (Unk) (View Cotareg Review and Cotareg Label ), FLECAINIDE ACETATE (Unk) (View Flecainide Acetate Review and Flecainide Acetate Label ). Patient was hospitalized.

4703215-8 | Dyspnoea, Hypocapnia, Hypoxia, Interstitial Lung Disease
on Jun 10, 2005 Female patient from , 74 years of age, weighting 176.4 lb, was diagnosed with hypertension, essential hypertension and was treated with Kerlone (View Usage). After Kerlone was administered, patient had the following side effects: dyspnoea, hypocapnia, hypoxia, interstitial lung disease. Kerlone dosage: . During the same period patient was treated with COTAREG (View Cotareg Review and Cotareg Label ), FLECAINE (View Flecaine Review and Flecaine Label ). Patient was hospitalized.

4694435-X | Dyspnoea, Hypocapnia, Hypoxia, Interstitial Lung Disease
Patient was taking Kerlone (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hypocapnia, hypoxia, interstitial lung disease on Jun 10, 2005 from Additional patient health information: Female patient , 74 years of age, weighting 176.4 lb, was diagnosed with cardiac failure, essential hypertension and. Kerlone dosage: . During the same period patient was treated with COTAREG (View Cotareg Review and Cotareg Label ), FLECAINE (View Flecaine Review and Flecaine Label ). Patient was hospitalized.

4690733-4 | Pneumonitis
Adverse event was reported on Jun 03, 2005 by a Female patient taking Kerlone (View Usage) (Dosage: Unk) was diagnosed with cardiac failure, essential hypertension and. Location: , 74 years of age, weighting 176.4 lb, Patient had the following side effects: pneumonitis. During the same period patient was treated with COTAREG (Unk) (View Cotareg Review and Cotareg Label ), FLECAINE (Unk) (View Flecaine Review and Flecaine Label ). Patient was hospitalized.

4620911-1 | Cholestasis, Cytolytic Hepatitis, Hepatitis A
on Mar 10, 2005 Female patient from , 77 years of age, was diagnosed with hypertension, hypothyroidism and was treated with Kerlone (View Usage). After Kerlone was administered, patient had the following side effects: cholestasis, cytolytic hepatitis, hepatitis a (What is hepatitis a?). Kerlone dosage: 20 Mg Od. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Mcg Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALDACTAZINE (SPIRONOLACTONE, ALTIZIDE) TABLET 25 MG (12.5 Mg Od) (View Aldactazine - (spironolactone, Altizide) - Tablet - 25 Mg Review and Aldactazine - (spironolactone, Altizide) - Tablet - 25 Mg Label ), HEXAQUINE (QUININE, THIAMINE) TABLET 160 MG (2 Unit) (View Hexaquine - (quinine, Thiamine) - Tablet - 160 Mg Review and Hexaquine - (quinine, Thiamine) - Tablet - 160 Mg Label ). Patient was hospitalized.

4585403-7 | Acute Prerenal Failure, Dehydration, Hyperuricaemia, Interstitial Lung Disease
on Jan 26, 2005 Male patient from , 80 years of age, was diagnosed with cardiac failure chronic and was treated with Kerlone (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, dehydration, hyperuricaemia, interstitial lung disease. Kerlone dosage: 2.5 Mg Po. During the same period patient was treated with NU LOTAN (LOSARTAN POTASSIUM) (View Nu-lotan (losartan Potassium) Review and Nu-lotan (losartan Potassium) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BAYASPIRIN (ASPIRIN) (View Bayaspirin (aspirin) Review and Bayaspirin (aspirin) Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIART (AZOSEMIDE) (View Diart (azosemide) Review and Diart (azosemide) Label ). Patient was hospitalized.